Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Memantinol vs Akatinol Memantine in Healthy Subjects
NCT03121820Phase 1Completed
- Sponsor
- Geropharm
- Start
- Oct 2016
- Primary completion
- Nov 2016
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in Alzheimer's disease (AD) (2 arms), sponsored by Geropharm. Primary endpoints: Area Under the Curve From Time Zero Extrapolated to Infinity at 72 hours and Observed Maximum Plasma Concentration at 72 hours. Started Oct 2016; status: completed.
02
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03121820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03121820.